Orexigen Therapeutics, Inc.
Orexigen Therapeutics, Inc. (OREX) is a publicly traded company in the Unknown sector. Across all available filings, 42 corporate insiders have executed 947 transactions totaling $219.2M, demonstrating a bullish sentiment with $125.6M in net insider flow. The most recent transaction on Mar 15, 2018 involved a sale of 1,694 shares valued at $407.
OREX Insider Activity Summary
Who Is Buying OREX Stock?
No significant insider buying has been recorded for OREX in the recent period.
Who Is Selling OREX Stock?
No significant insider selling has been recorded for OREX in the recent period.
Is Orexigen Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for OREX is bullish with an Insider Alignment Score of 79/100 and a net flow of $125.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
OREX Frequently Asked Questions
Understanding OREX Insider Activity
Insider trading at Orexigen Therapeutics, Inc. (OREX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 42 insiders are actively trading OREX stock, having executed 947 transactions in the past 90 days. The most active insider is Kathleen K. Schoemaker (Executive), who has made 48 transactions totaling $25.9M.
Related Tools
Track Orexigen Therapeutics, Inc. Insider Activity
Get notified when executives and directors at OREX file new Form 4 transactions